Published 3 days ago • loading... • Updated 2 days ago

Weekly Mim8 Effective in Pediatric Hemophilia A With and Without Inhibitors

Summary by Pharmacy Times

The new data demonstrates the effectiveness of Mim8 in children with hemophilia A regardless of inhibitor status, expanding the populations in which the novel drug in development could have a treatment benefit.

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All

Left

Center

Right

Pharmacy Times

Weekly Mim8 Effective in Pediatric Hemophilia A With and Without Inhibitors

2 days ago

Read Full Article

Patient Worthy

Novo Nordisk reports positive data for pediatric use in hemophilia A clinical trial – Patient Worthy

Novo Nordisk plans to seek approval in the US and the EU this year for their drug Mim8 for use on pediatric patients with Hemophilia A after promising results from its FRONTIER3 trial. As reported by FIERCE Biotech, Phase 1 of the trial consisted of 70 children between the ages of 1 and 11 who […]

3 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right